ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
ANI Pharmaceuticals has received FDA approval and launched its generic Isosorbide Mononitrate Tablet USP, in 10 mg and 20 mg strengths, marking a strategic expansion in its generics business. This product launch underscores the company's commitment to delivering limited-competition, high-quality pharmaceutical products and highlights its robust R&D…